Literature DB >> 747401

Menkes's syndrome. Report of a patient treated from 21 days of age with parenteral copper.

P Daish, E M Wheeler, P F Roberts, R D Jones.   

Abstract

In an infant with Menkes's steely-hair syndrome, early treatment (from 21 days of age) with parenteral copper failed to halt the disease. In addition to urinary tract abnormalities, panlobular emphysema was present a finding not previously noted in the syndrome.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 747401      PMCID： PMC1545159          DOI： 10.1136/adc.53.12.956

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Menkes's steely hair syndrome.

Authors:  E M Wheeler; P F Roberts
Journal:  Arch Dis Child       Date:  1976-04       Impact factor: 3.791

2.  A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration.

Authors:  J H MENKES; M ALTER; G K STEIGLEDER; D R WEAKLEY; J H SUNG
Journal:  Pediatrics       Date:  1962-05       Impact factor: 7.124

3.  Changes in total, nondiffusible, and diffusible plasma zinc and copper during infancy.

Authors:  R I Henkin; J D Schulman; C B Schulman; D A Bronzert
Journal:  J Pediatr       Date:  1973-05       Impact factor: 4.406

4.  Therapeutic implications of copper deficiency in Menkes's steely-hair syndrome.

Authors:  J A Walker-Smith; B Turner; J Blomfield; G Wise
Journal:  Arch Dis Child       Date:  1973-12       Impact factor: 3.791

5.  Copper infusion therapy in trichopoliodystrophy.

Authors:  W D Grover; M C Scrutton
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406
  5 in total
  9 in total

1.  Reduced lysyl oxidase activity in skin fibroblasts from patients with Menkes' syndrome.

Authors:  P M Royce; J Camakaris; D M Danks
Journal:  Biochem J       Date:  1980-11-15       Impact factor: 3.857

2.  Bone marrow from blotchy mice is dispensable to regulate blood copper and aortic pathologies but required for inflammatory mediator production in LDLR-deficient mice during chronic angiotensin II infusion.

Authors:  Devon Harris; Yuanyuan Liang; Cang Chen; Senlin Li; Om Patel; Zhenyu Qin
Journal:  Ann Vasc Surg       Date:  2014-10-29       Impact factor: 1.466

3.  The failure of parenteral copper therapy in Menkes Kinky Hair syndrome.

Authors:  A D Garnica
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

4.  Copper metabolism in mottled mouse mutants. The effect of copper therapy on lysyl oxidase activity in brindled (Mobr) mice.

Authors:  P M Royce; J Camakaris; J R Mann; D M Danks
Journal:  Biochem J       Date:  1982-02-15       Impact factor: 3.857

5.  Menkes' disease: long-term treatment with copper and D-penicillamine.

Authors:  D Nadal; K Baerlocher
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

6.  Brindled mottled mouse: morphological changes of brain and visceral organs in hemizygous males following copper supplementation.

Authors:  K Suzuki; H Nagara
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

7.  The effect of copper supplementation on the concentration of copper in the brain of the brindled mouse.

Authors:  G Wenk; K Suzuki
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

Review 8.  Menkes disease: what a multidisciplinary approach can do.

Authors:  Rahul Ojha; Asuri N Prasad
Journal:  J Multidiscip Healthc       Date:  2016-08-17

9.  Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale.

Authors:  Rob Janssen; Emiel Fm Wouters; Wim Janssens; Willeke F Daamen; Paul Hagedoorn; Hugo Ajm de Wit; Jef Serré; Ghislaine Gayan-Ramirez; Frits Me Franssen; Niki L Reynaert; Jan H von der Thüsen; Henderik W Frijlink
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.